Cargando…

Postnatal Growth Trajectories and Neurodevelopmental Outcomes Following Bevacizumab Treatment for Retinopathy of Prematurity

PURPOSE: To investigate the postnatal growth and neurodevelopment of infants with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB). PATIENTS AND METHODS: This was a retrospective comparative study. A total of 262 infants were divided among three study groups: 22 treated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, David L, Yoon, Hawke H, deRegnier, Raye-Ann O, Arzu, Jennifer, Rahmani, Safa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401100/ https://www.ncbi.nlm.nih.gov/pubmed/36035240 http://dx.doi.org/10.2147/OPTH.S378520

Ejemplares similares

Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment
por: Lien, Reyin, et al.
Publicado: (2016)

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019)

Survival and major neurodevelopmental impairment in extremely low gestational age newborns born 1990–2000: a retrospective cohort study
por: Washburn, Lisa K, et al.
Publicado: (2007)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Abrishami, Majid, et al.
Publicado: (2021)

Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity
por: Arima, Mitsuru, et al.
Publicado: (2020)

Validation of the Postnatal Growth and Retinopathy of Prematurity (GROP) screening criteria
por: Fadakar, Kaveh, et al.
Publicado: (2022)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
por: Blair, Michael, et al.
Publicado: (2018)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Severe Retinopathy of Prematurity Associated With Neurodevelopmental Disorder in Children
por: Choi, Young-Jin, et al.
Publicado: (2022)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
por: Minami, Tsuyoshi, et al.
Publicado: (2014)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
por: Riazi-esfahani, Hamid, et al.
Publicado: (2021)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
por: Pawar, Neelam, et al.
Publicado: (2023)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Prenatal and Postnatal Inflammation-Related Risk Factors for Retinopathy of Prematurity
por: Goldstein, Gregory P., et al.
Publicado: (2019)

POOR POSTNATAL WEIGHT GAIN AS A PREDICTOR OF RETINOPATHY OF PREMATURITY
por: Behin Šarić, Ivana, et al.
Publicado: (2020)

Retrospective validation of the postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria in a Swiss cohort
por: Vinayahalingam, Nithursa, et al.
Publicado: (2022)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
por: Islam, Yasmin, et al.
Publicado: (2020)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
por: Kara, Caner, et al.
Publicado: (2017)

Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
por: Bazvand, Fatemeh, et al.
Publicado: (2021)

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
por: Huang, Ching-Yen, et al.
Publicado: (2022)

Neurodevelopmental Outcomes in Postnatal Growth-Restricted Preterm Infants with Postnatal Head-Sparing
por: Meyers, Jeffrey M., et al.
Publicado: (2016)

Severe Retinopathy of Prematurity Is Not Independently Associated With Worse Neurodevelopmental Outcomes in Preterm Neonates
por: Altendahl, Marie, et al.
Publicado: (2021)

Association between severe retinopathy of prematurity (ROP) and poor motor neurodevelopmental outcome
por: Godugu, Swathi, et al.
Publicado: (2023)

Role of deferred retinal laser following intravitreal injection of bevacizumab in treatment of severe retinopathy of prematurity
por: Bhat, Vishalakshi, et al.
Publicado: (2023)

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity
por: Tokgöz, Orhan, et al.
Publicado: (2013)

Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity
por: Karkhaneh, Reza, et al.
Publicado: (2018)

Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study
por: Ghassemi, Fariba, et al.
Publicado: (2022)

Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
por: Sjöbom, Ulrika, et al.
Publicado: (2021)

Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: A systematic review and meta-analysis
por: Diggikar, Shivashankar, et al.
Publicado: (2023)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
por: Shoeibi, Nasser, et al.
Publicado: (2018)

Longitudinal Development of Refractive Error in Children Treated With Intravitreal Bevacizumab or Laser for Retinopathy of Prematurity
por: Simmons, Michael, et al.
Publicado: (2021)

Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
por: Hellgren, Gunnel, et al.
Publicado: (2017)

Cluster Analysis of Early Postnatal Biochemical Markers May Predict Development of Retinopathy of Prematurity
por: Markasz, Laszlo, et al.
Publicado: (2020)

Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) Study
por: Zupancic, John A. F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c8b5i5sd5rd9lugj7l842f2b1f